These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16418280)

  • 1. IA-2beta, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion.
    Doi A; Shono T; Nishi M; Furuta H; Sasaki H; Nanjo K
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):885-90. PubMed ID: 16418280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells.
    Wang Y; Nishi M; Doi A; Shono T; Furukawa Y; Shimada T; Furuta H; Sasaki H; Nanjo K
    FEBS Lett; 2010 Apr; 584(8):1503-8. PubMed ID: 20206170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice.
    Kubosaki A; Gross S; Miura J; Saeki K; Zhu M; Nakamura S; Hendriks W; Notkins AL
    Diabetes; 2004 Jul; 53(7):1684-91. PubMed ID: 15220191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion.
    Harashima S; Clark A; Christie MR; Notkins AL
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8704-9. PubMed ID: 15939893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion.
    Ohsugi M; Cras-Méneur C; Zhou Y; Bernal-Mizrachi E; Johnson JD; Luciani DS; Polonsky KS; Permutt MA
    J Biol Chem; 2005 Feb; 280(6):4992-5003. PubMed ID: 15546857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells.
    Seissler J; Nguyen TB; Aust G; Steinbrenner H; Scherbaum WA
    Diabetes; 2000 Jul; 49(7):1137-41. PubMed ID: 10909970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice.
    Xu H; Abuhatzira L; Carmona GN; Vadrevu S; Satin LS; Notkins AL
    Diabetologia; 2015 Oct; 58(10):2298-306. PubMed ID: 26141787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets.
    Colombo M; Gregersen S; Xiao J; Hermansen K
    Pancreas; 2003 Aug; 27(2):161-6. PubMed ID: 12883265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells.
    Wierup N; Yang S; McEvilly RJ; Mulder H; Sundler F
    J Histochem Cytochem; 2004 Mar; 52(3):301-10. PubMed ID: 14966197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents.
    Dezaki K; Hosoda H; Kakei M; Hashiguchi S; Watanabe M; Kangawa K; Yada T
    Diabetes; 2004 Dec; 53(12):3142-51. PubMed ID: 15561944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin signalling in β-cells regulates insulin secretion and blood glucose.
    Yada T; Damdindorj B; Rita RS; Kurashina T; Ando A; Taguchi M; Koizumi M; Sone H; Nakata M; Kakei M; Dezaki K
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():111-7. PubMed ID: 25200304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance.
    Dezaki K; Sone H; Koizumi M; Nakata M; Kakei M; Nagai H; Hosoda H; Kangawa K; Yada T
    Diabetes; 2006 Dec; 55(12):3486-93. PubMed ID: 17130496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice.
    Kubosaki A; Nakamura S; Notkins AL
    Diabetes; 2005 Dec; 54 Suppl 2():S46-51. PubMed ID: 16306340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R.
    Pradhan G; Wu CS; Han Lee J; Kanikarla P; Guo S; Yechoor VK; Samson SL; Sun Y
    Sci Rep; 2017 Apr; 7(1):979. PubMed ID: 28428639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.
    Lu J; Li Q; Xie H; Chen ZJ; Borovitskaya AE; Maclaren NK; Notkins AL; Lan MS
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2307-11. PubMed ID: 8637868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion in islets from mice with a double knockout for the dense core vesicle proteins islet antigen-2 (IA-2) and IA-2beta.
    Henquin JC; Nenquin M; Szollosi A; Kubosaki A; Notkins AL
    J Endocrinol; 2008 Mar; 196(3):573-81. PubMed ID: 18310453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
    Notkins AL; Zhang B; Matsumoto Y; Lan MS
    J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion.
    Saeki K; Zhu M; Kubosaki A; Xie J; Lan MS; Notkins AL
    Diabetes; 2002 Jun; 51(6):1842-50. PubMed ID: 12031972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of proinflammatory cytokines on gene expression of the diabetes-associated autoantigen IA-2 in INS-1 cells.
    Steinbrenner H; Nguyen TB; Wohlrab U; Scherbaum WA; Seissler J
    Endocrinology; 2002 Oct; 143(10):3839-45. PubMed ID: 12239095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of rat insulin II promoter-ghrelin transgenic mice and rat glucagon promoter-ghrelin transgenic mice.
    Iwakura H; Hosoda K; Son C; Fujikura J; Tomita T; Noguchi M; Ariyasu H; Takaya K; Masuzaki H; Ogawa Y; Hayashi T; Inoue G; Akamizu T; Hosoda H; Kojima M; Itoh H; Toyokuni S; Kangawa K; Nakao K
    J Biol Chem; 2005 Apr; 280(15):15247-56. PubMed ID: 15701644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.